Mandinka2
New member
THought about throwin this up on the female board but then said screw it , most folks here are guys with gfs/wives:
http://www.unison.ie/irish_independent/stories.php3?ca=9&si=1025054&issue_id=9615
HRT can double the risk of breast cancer
WOMEN were warned yesterday that hormone replacement therapy can cause breast cancer.
New research shows that the risk of developing the cancer is doubled for women taking combined therapy, which contains the hormones oestrogen and progestogen.
But all forms of the therapy increase the risk and the longer it is taken the greater the risk, scientists said.
Women taking oestrogen-only HRT increase their risk by 30pc, the research found. It was conducted on more than a million women in Britain - the biggest study of its kind and it found HRT is responsible for 2,000 cases of breast cancer a year in Britain where a total of 1.5m women take HRT.
The study, by the Medical Research Council and Cancer Research UK, found that for every 1,000 post-menopausal women who had taken HRT for 10 years, those on oestrogen-only HRT developed an extra five breast cancers. Post-menopausal women using combined oestrogen-progestogen treatment for 10 years were at three times greater risk, developing an extra 19 cases of breast cancer.
Previous research in America estimated that HRT would cause only one extra case per 1,000 women.
The new study also shows that the adverse effect of HRT can be seen sooner than scientists had first thought, with the increased risk of breast cancer starting after a year.
The results, published in The Lancet, the British medical journal, pose a huge dilemma for women and for doctors in balancing the benefits of HRT against the cancer risk.
The British government's medical watchdog, the Committee on the Safety of Medicines, issued urgent advice last night telling all GPs to discuss the findings of the study with patients. Thousands of women are expected to abandon the therapy, once hailed as a miracle answer to the menopause.
Dr John Toy, medical director of Cancer Research UK, which funded the study, said: "A woman wanting to take HRT for a long time would be wise to consider carefully the findings of this large study and other relevant research." But he said the new results did not create an "emergency situation".
In a commentary published alongside the study, Professor Chris van Weel, of the Department of General Practice and Social Medicine, at the University of Nijmegen in the Netherlands, said women should stop HRT altogether.
"The problem is in those women who are already, often for a long time, taking HRT," he said. "This group should discontinue HRT use as soon as possible. Discontinuing HRT should be suggested in as supportive a way as possible."
Professor Valerie Beral, Director of the Cancer Research UK Epidemiology Unit, said that women should weigh up the risks carefully. "Combined oestrogen-progestagen HRT is usually prescribed for women who still have a uterus, to avoid the increased risk of cancer of the uterus caused by oestrogenonly therapy," she said.
"Since our results show a substantially greater increase in breast cancer with combined HRT, women need to weigh the increased risk of breast cancer caused by the addition of progestagen against the lowered risk of uterine cancer."
A spokeswoman for Women's Health Concern, a British helpline which advises women on the menopause, said: "We are worried this is going to cause a panic. Our advice would be to go to see your GP. You have to weigh up these risks against the benefits from HRT.
"The findings mean that it is even more important that each decision to start HRT is made on an individual basis, and is reassessed at least annually."
Celia Hall
in London
http://www.unison.ie/irish_independent/stories.php3?ca=9&si=1025054&issue_id=9615
HRT can double the risk of breast cancer
WOMEN were warned yesterday that hormone replacement therapy can cause breast cancer.
New research shows that the risk of developing the cancer is doubled for women taking combined therapy, which contains the hormones oestrogen and progestogen.
But all forms of the therapy increase the risk and the longer it is taken the greater the risk, scientists said.
Women taking oestrogen-only HRT increase their risk by 30pc, the research found. It was conducted on more than a million women in Britain - the biggest study of its kind and it found HRT is responsible for 2,000 cases of breast cancer a year in Britain where a total of 1.5m women take HRT.
The study, by the Medical Research Council and Cancer Research UK, found that for every 1,000 post-menopausal women who had taken HRT for 10 years, those on oestrogen-only HRT developed an extra five breast cancers. Post-menopausal women using combined oestrogen-progestogen treatment for 10 years were at three times greater risk, developing an extra 19 cases of breast cancer.
Previous research in America estimated that HRT would cause only one extra case per 1,000 women.
The new study also shows that the adverse effect of HRT can be seen sooner than scientists had first thought, with the increased risk of breast cancer starting after a year.
The results, published in The Lancet, the British medical journal, pose a huge dilemma for women and for doctors in balancing the benefits of HRT against the cancer risk.
The British government's medical watchdog, the Committee on the Safety of Medicines, issued urgent advice last night telling all GPs to discuss the findings of the study with patients. Thousands of women are expected to abandon the therapy, once hailed as a miracle answer to the menopause.
Dr John Toy, medical director of Cancer Research UK, which funded the study, said: "A woman wanting to take HRT for a long time would be wise to consider carefully the findings of this large study and other relevant research." But he said the new results did not create an "emergency situation".
In a commentary published alongside the study, Professor Chris van Weel, of the Department of General Practice and Social Medicine, at the University of Nijmegen in the Netherlands, said women should stop HRT altogether.
"The problem is in those women who are already, often for a long time, taking HRT," he said. "This group should discontinue HRT use as soon as possible. Discontinuing HRT should be suggested in as supportive a way as possible."
Professor Valerie Beral, Director of the Cancer Research UK Epidemiology Unit, said that women should weigh up the risks carefully. "Combined oestrogen-progestagen HRT is usually prescribed for women who still have a uterus, to avoid the increased risk of cancer of the uterus caused by oestrogenonly therapy," she said.
"Since our results show a substantially greater increase in breast cancer with combined HRT, women need to weigh the increased risk of breast cancer caused by the addition of progestagen against the lowered risk of uterine cancer."
A spokeswoman for Women's Health Concern, a British helpline which advises women on the menopause, said: "We are worried this is going to cause a panic. Our advice would be to go to see your GP. You have to weigh up these risks against the benefits from HRT.
"The findings mean that it is even more important that each decision to start HRT is made on an individual basis, and is reassessed at least annually."
Celia Hall
in London